Advertisement
Research Article| Volume 7, ISSUE 3, P583-613, July 1991

Intropic Agents

Catecholamines, Digoxin, Amrinone
  • Daniel A. Notterman
    Correspondence
    Address reprint requests to: Daniel A. Notterman, MD, FAAP, FCCM, Division of Pediatric Critical Care Medicine, The New York Hospital, 525 East 68th Street, Room N-309, New York, NY 10021
    Affiliations
    Associate Professor of Pediatrics, Clinical Pharmacology, and Surgery, Cornell University Medical College; and Director, Division of Pediatric Critical Care Medicine, The New-York Hospital, New York, New York
    Search for articles by this author
DOI:https://doi.org/10.1016/S0749-0704(18)30297-5
Intropic Agents
Previous ArticleNitroprusside, Nitroglycerin, and Angiotensin-Converting Enzyme Inhibitors
Next ArticleOpioids and Other Analgesics
      This paper is only available as a PDF. To read, Please Download here.
      Agents used to support the failing circulation have been associated with many adverse effects. The most serious involve tachycardia, dysrhythmias, increased myocardial oxygen consumption, and excessive vasoconstriction. Metabolic, pulmonary, renal, and hematologic function may also be affected. Although each of the compounds reviewed can produce life-threatening complications, appropriate selection and monitoring minimize these unfavorable events.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Alexander C.S.
        • Sako Y.
        • Mikulic E.
        Pedal gangrene associated with use of dopamine.
        N Engl J Med. 1975; 293: 591
        • Alquist R.P.
        A study of adrenotropic receptors.
        Am J Physiol. 1948; 153: 586
        • Amy J.J.
        • Karum S.M.
        Intrauterine administration of L-noradrenaline and propranolol during the second trimester of pregnancy.
        Journal of Obstetrics and Gynecology of the British Commonwealth. 1974; 81: 75
        • Ansell J.
        • Tiarks C.
        • McCue J.
        • et al.
        Amrinone-induced thrombocytopenia.
        Arch Intern Med. 1984; 144: 949
        • Aronson J.K.
        Positive inotropic drugs and drugs used in dysrhythmias (chapter 18.
        in: Dukes M.N.G. Meyler's Side Effects of Drugs. ed 11. Elsevier, Amsterdam1988: 333
        • Baldessarini P.J.
        Drugs and the treatment of psychiatric disorders (Chapter 19.
        in: Gilman A.G. Goodman L.S. Rail T.W. et a.l. The Pharmacologic Basis of Therapeutics. ed 7. Macmillan, New York1985
        • Barger G.
        • Dale H.H.
        Chemical structure and sympathomimetic action of amines.
        J Physiol. 1932; 126: 237
        • Barrazzone C.
        • Jaccard C.
        • Berner M.
        • et al.
        Propranolol treatment in children with tetralogy of Fallot alters the response to isoprenaline after surgical repair.
        Br Heart J. 1988; 60: 2
        • Beller G.A.
        • Smith T.W.
        • Abelmann W.H.
        • et al.
        Digitalis intoxication: A prospective clinical study with serum level correlations.
        N Engl J Med. 1971; 284: 989
        • Benotti J.R.
        • Grossman W.
        • Braunwald E.
        • et al.
        Hemodynamic assessment of amrinone: A new inotropic agent.
        N Engl J Med. 1978; 299: 1373
        • Benotti J.R.
        • Grossman W.
        • Braunwald E.
        • et al.
        Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
        Circulation. 1980; 62: 28
        • Benotti J.R.
        • McCue J.E.
        • Alpert J.S.
        Comparative vasoactive therapy for heart failure.
        Am J Cardiol. 1985; 56: 19B
        • Benowitz N.
        • Forsyth R.P.
        • Melmon K.L.
        • et al.
        Lidocaine disposition kinetics in monkey and man. Effects of hemorrhage and sympathomimetic drug administration.
        Clin Pharmacol Ther. 1974; 16: 99
        • Beregovich J.
        • Bianchi C.
        • Rubier S.
        Dose-related hemodynamic and renal effects of dopamine in congestive heart failure.
        Am Heart J. 1974; 87: 550
        • Bernat J.L.
        • Sullivan J.K.
        Trigeminal neuralgia from digitalis intoxication.
        JAMA. 1979; 241: 164
        • Bierman H.R.
        • et al.
        The release of leukocytes and platelets from the pulmonary circulation by epinephrine.
        Blood. 1952; 7: 683
        • Bigger J.T.
        • Leahey E.B.
        Quinidine and digoxin: An important interaction.
        Drugs. 1982; 24: 229
        • Binah O.
        • Sodowick B.
        • Vulliemox Y.
        The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
        Circulation. 1986; 73: 3
        • Bohn D.J.
        • Poirier C.S.
        • Edmonds J.F.
        Hemodynamic effects of dobutamine after cardiopulmonary bypass in children.
        Crit Care Med. 1980; 8: 367
        • Bottorff M.B.
        • Rutledge D.R.
        • Pieper J.A.
        Evaluation of intravenous amrinone: The first of a new class of positive inotropic agents with vasodilator properties.
        Pharmacotherapy. 1985; 5: 227
        • Bowman W.C.
        Effects of adrenergic activators and inhibitors on the skeletal muscles. Adrenergic Activators and Inhibitors.
        in: Szekeres L. Handbook of Experimental Pharmacology. Springer-Verlag, Berlin1981 (vol. 54, pt II)
        • Braunstein K.M.
        • Sarji K.E.
        • Kleinfelder J.
        • et al.
        The effects of dopamine on human platelet aggregation in vitro.
        J Pharmacol Exp Ther. 1977; 200: 449

      23. Brown MJ, Brown DC, Murphy MB: Hypokalemia from β2-receptor stimulation by circulating epinephrine. N Engl J Med 23:1414

        • Buchanan N.
        • Cane R.D.
        • Miller M.
        Symmetrical gangrene of the extremities associated with the use of dopamine subsequent to ergometrine administration.
        Intensive Care Med. 1977; 3: 55
        • Carter B.T.
        • Westfall V.K.
        • Heironimus T.W.
        • et al.
        Severe reaction to accidental subcutaneous administration of large doses of epinephrine.
        Anesth Analg. 1971; 50: 175
        • Chatterjee K.
        Phosphodiesterase inhibitors: Alterations in systemic and coronary hemodynamics.
        Basic Res Cardiol. 1989; 84: 213
        • Chernow B.
        • Rainey T.
        • Lake R.
        Endogenous and exogenous catecholamines in critical care medicine.
        Crit Care Med. 1982; 10: 409
        • Chung E.K.
        Digitalis Intoxication. Excerpta Medica, Amsterdam1969
        • Colucci W.
        • Wright R.
        • Braunwald E.
        New positive inotropic agents in the treatment of congestive heart failure.
        N Engl J Med. 1986; 314 (291 (part 1) and 349 (part 2)
        • Corr P.B.
        Mechanisms contributing to the arrhythmogenic influences of α1-adrenergic stimulation of the ischemic heart.
        Am J Med. 1989; 87 (suppl 2A):: 19S
        • Cryer P.E.
        Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system.
        N Engl J Med. 1980; 303: 8
        • Desjars P.
        • Pinaud M.
        • Bugnon D.
        • et al.
        Norepinephrine therapy has no deleterious renal effects in human septic shock.
        Crit Care Med. 1989; 17: 426
      33. Digoxin antibody fragments for digitalis toxicity.
        Med Lett Drugs Ther. 1986; 28: 87
        • Di Sesa V.J.
        • Gold J.P.
        • Shemin R.J.
        • et al.
        Comparison of dopamine and dobutamine in patients requiring postoperative circulatory support.
        Clin Cardiol. 1986; 9: 253
        • Dollery C.T.
        Physiological and pharmacological interactions of antihypertensive drugs.
        Proc R Soc Med. 1965; 58: 983
        • Dutz W.
        Drugs affecting autonomic functions of the extrapyramidal system (chapter 14.
        in: Dukes M.N.G. Meyler's Side Effects of Drugs. ed 11. Elsevier, Amsterdam1988: 258
        • Edelson J.
        • Stroshane R.
        • Benziger D.P.
        • et al.
        Pharmacokinetics of the bipyridines amrinone and milrinone.
        Circulation. 1986; 73 (145): 111
        • Endoh M.
        • Yamashita S.
        • Taira N.
        Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
        J Pharmacol Exp Ther. 1982; 221: 775
        • Evans D.B.
        Modulation of cAMP: Mechanism for positive inotropic action.
        J Cardiovasc Pharm. 1986; 9 (suppl):: 522
        • Feldschuh J.
        • Gambino R.
        Extreme central acidosis from Abbott epinephrine.
        Am J Med. 1983; 74: 32
        • Fowler M.B.
        • Alderman E.L.
        • Oesterk S.N.
        • et al.
        Dobutamine and dopamine after cardiac surgery: Greater augmentation of myocardial blood flow with dobutamine.
        Circulation. 1984; 70 (suppl I):: 103
        • Fukuoka T.
        • Nishimura M.
        • Imanaka H.
        • et al.
        Effects of norepinephrine on renal function in septic patients with normal and elevated serum lactate levels.
        Crit Care Med. 1989; 17: 1104
        • Gillespie T.A.
        • Roberts R.
        • Ambos H.D.
        Salutary effects of dobutamine on hemodynamics without exacerbation of arrhythmia or myocardial injury.
        Circulation. 1975; 76 ((suppl 11): 51
        • Goenen M.
        • Pedemonte O.
        • Baele P.
        • et al.
        Amrinone in the management of low cardiac output after open heart surgery.
        Am J Cardiol. 1985; 56: 33B
        • Golbranson F.L.
        • Lurie L.
        • Vance R.M.
        • et al.
        Multiple extremity amputations in hypotensive patients treated with dopamine.
        JAMA. 1980; 243: 1145
        • Goldberg L.I.
        Dopamine—clinical use of an endogenous catecholamine.
        N Engl J Med. 1974; 291: 707
        • Greene S.I.
        • Smith J.W.
        Dopamine gangrene.
        N Engl J Med. 1976; 294: 114
        • Haft J.I.
        • Kranz P.D.
        • Albert F.J.
        • et al.
        Intravascular platelet aggregation in the heart induced by norepinephrine: Microscopic studies.
        Circulation. 1972; 46: 698
        • Hansten P.D.
        • Horn J.R.
        Drug Interactions. ed 6. Lea & Febiger, Philadelphia1989
        • Hamilton R.A.
        • Kowalsky S.F.
        • Wright E.M.
        • et al.
        Effect of the acetylator phenotype on amrinone pharmacokinetics.
        Clin Pharm Ther. 1986; 40: 615
        • Hamstreet M.P.
        • Miles M.V.
        • Rutland R.O.
        Effect of intravenous isoproterenol on theophylline kinetics.
        J Allergy Clin Immunol. 1982; 69: 360
        • Harvey P.W.
        • Purnell G.V.
        Fatal case of gas gangrene associated with intramuscular injections.
        Br Med J. 1968; 1: 744
        • Heinonen O.P.
        • Slone D.
        • Shapiro S.
        Birth Defects and Drugs in Pregnancy. Publishing Sciences Group, Littleton1977: 287
        • Hirsch I.A.
        • Zauder H.L.
        Chloral hydrate: A potential cause of arrhythmias.
        Anesth Analg. 1986; 65: 691
        • Hoffman B.F.
        • Bigger Jr, J.T.
        Digitalis and allied cardiac glycosides.
        in: Goodman A. Gilman L.S. Rail T. et a.l. The Pharmacological Basis of Therapeutics. ed, 7. Macmillan, New York1985 ((chapter 30)
        • Horak A.
        • Raine R.
        • Opie L.H.
        • et al.
        Severe ischaemia induced by intravenous adrenaline.
        Br Med J (Clin Res. 1983; 286: 519
        • Houben H.
        • Thien T.
        • De Boo T.
        • et al.
        Influence of selective and non-selective (β-adrenoreceptor blockade on the haemodynamic effect of adrenaline during combined antihypertensive drug therapy.
        Clin Sci. 1979; 57: 397s
        • Johnston R.R.
        • Eger II, E.L.
        • Wilson C.
        A comparative interaction of epinephrine with enflurane, isoflurane and halothane in man.
        Anesth Analg. 1976; 55: 709
        • Katz A.M.
        Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure.
        N Engl J Med. 1990; 322: 100
        • Kupper W.
        • Waller D.
        • Hanrath P.
        • et al.
        Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease.
        Eur Heart J. 1982; 3: 29
        • Kurachek S.C.
        • Rockoff M.A.
        Inadvertent intravenous administration of racemic epinephrine.
        JAMA. 1985; 253: 1441
        • Kurland G.
        • Williams J.
        • Lewiston N.J.
        Fatal myocardial toxicity during continuous infusion intravenous isoproterenol therapy of asthma.
        J Allergy Clin Immunol. 1979; 63: 407
        • Lands A.M.
        • Arnold A.
        • McAuliff J.P.
        • et al.
        Differentiation of receptors systems activated by sympathomimetic amines.
        Nature. 1967; 214: 597
        • Lands A.M.
        • Luduena F.P.
        • Buzzo H.J.
        Differentiation of receptors responsive to isoproterenol.
        Life Sci. 1967; 6: 2241
        • Langer S.Z.
        Presynaptic regulation of catecholamine release.
        Br J Pharmacol. 1974; 60: 481
        • Lathers C.M.
        • Roberts J.
        Minireview: Digitalis cardiotoxicity revisited.
        Life Sci. 1980; 27: 1713
        • Lawless S.
        • Burckart G.
        • Diven W.
        • et al.
        Amrinone in neonates and infants after cardiac surgery.
        Crit Care Med. 1989; 17: 751
        • Leier C.V.
        • Heban P.T.
        • Huss P.
        • et al.
        Comparative systemic and regional hemodynamic effects of dopamine and 'dobutamine in patients with cardiomyopathic heart failure.
        Circulation. 1978; 58: 466
        • Leier C.V.
        • Unverferth D.V.
        Diagnosis and treatment: Drugs 5 years later: Dobutamine.
        Ann Intern Med. 1983; 99: 490
        • Leier C.V.
        • Unverferth D.V.
        • Kates R.E.
        The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure.
        Am J Med. 1979; 66: 238
        • Lejemtel T.
        • Sonnenblick E.H.
        Should the failing heart be stimulated?.
        N Engl J Med. 1984; 21: 1384
        • Lemaire F.
        Effect of catecholamines on pulmonary right-to-left shunt.
        Int Anesthesiol Clin. 1983; 21: 43
        • Levine D.H.
        • Levkoff A.H.
        • Pappu L.D.
        • et al.
        Renal failure and other serious sequelae of epinephrine toxicity in neonates.
        South Med J. 1985; 78: 874
        • Lewin N.A.
        • Goldfrank L.R.
        • Howland M.A.
        • et al.
        Digitalis.
        in: Goldfrank L.R. Flomenbaum N.E. Lewin N.A. et a.l. Toxicologic Emergencies. ed 4. 1986 (chapter 35. Norwalk, Appleton-Century-Crofts)
        • Lewis R.P.
        Digitalis: A drug that refuses to die.
        Crit Care Med. 1990; 18: S5
        • Lippmann M.
        • Reisner L.S.
        Epinephrine injection with enflurane anesthesia: Incidence of cardiac arrhythmias.
        Anesth Analg. 1974; 53: 886
        • Loeb H.
        • et al.
        Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with cardiac failure.
        Circulation. 1975; 52 (suppl II):: 76
        • Loughnan P.M.
        Digoxin excretion in human breast milk.
        J Pediatr. 1978; 92: 1019
        • Magorien R.D.
        • Unverferth D.V.
        • Brown G.P.
        • et al.
        Dobutamine and hydralazine: Com parative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure.
        J Am Coll Cardiol. 1983; 1: 499
        • Matson J.R.
        • Loughlin G.M.
        • Strunk R.C.
        Myocardial ischemia complicating the use of isoproterenol in asthmatic children.
        J Pediatr. 1978; 92: 776
        • Medenica R.
        • Hatam K.
        • Hatam V.
        • et al.
        Digitoxin-induced thrombocytopenia.
        Int Arch Allergy Appl Immunol. 1972; 43: 1
        • Michell R.H.
        Post-receptor signalling pathways.
        Lancet. 1989; 1: 765
        • Minneman K.P.
        α1adrenergic receptor subtypes, inositol phosphates, and sources of cell Ca2+.
        Pharmacol Rev. 1988; 40: 87
        • Muelheims G.H.
        • Entrup R.W.
        • Paiewonsky D.
        • et al.
        Increased sensitivity of the heart to catecholamine-induced arrhythmias following guanethidine.
        Clin Pharmacol Ther. 1965; 6: 757
        • Mueller H.
        • Ayres S.M.
        • Gregory J.J.
        • et al.
        Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response to L-norepinephrine and isoproterenol.
        J Clin Invest. 1970; 49: 1885

      86. Notterman, DA: Pharmacology of the cardiovascular system (chapter 31). In Fuhrman BP, Zimmerman JJ: Pediatric Critical Care. St Louis, CV Mosby Co, in press

        • Ordog G.l.
        • Beneron S.
        Serum digoxin levels and mortality in 5100 patients.
        Ann Emerg Med. 1987; 16: 32
        • O'Rourke P.P.
        • Crone R.K.
        Effect of isoproterenol on measured theophylline levels.
        Crit Care Med. 1974; 12: 373
        • Packer M.
        • Medina N.
        • Yushak M.
        Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
        Circulation. 1984; 4: 855
        • Pacold I.
        • Kleinman B.
        • Gunnar R.
        • et al.
        Effects of low-dose dobutamine on coronary hemodynamics, myocardial metabolism, and anginal threshold in patients with coronary artery disease.
        Circulation. 1983; 68: 1044
        • Page R.
        • Gay W.
        • Friday G.
        • et al.
        Isoproterenol-associated myocardial dysfunction during status asthmaticus.
        Ann Allergy 57:402. 1986; 57: 429
        • Park M.K.
        Use of digoxin in infants and children, with specific emphasis on dosage.
        J Pediatr. 1986; 108: 871
      93. Product information: Digibind, Digoxin Immune Fab (Ovine. Burroughs Wellcome, Research Triangle Park, NC1990
      94. Product Information: Intropin, dopamine. Du Pont Pharmaceuticals, Wilmington1989
        • Rennotte M.T.
        • Reynaert M.
        • Clerbaux T.
        • et al.
        Effects of two inotropic drugs, dopamine and dobutamine, on pulmonary gas exchange in artificially ventilated patients.
        Intensive Care Med. 1989; 15: 160
        • Rocci Jr, M.L
        • Wilson H.
        The pharmacokinetics and pharmacodynamics of newer inotropic agents.
        Clin Pharmacokinet. 1987; 13: 91
        • Rodin S.M.
        • Johnson B.F.
        Pharmacokinetic interactions with digoxin.
        Clin Pharmacokinet. 1988; 15: 227
        • Rogers M.C.
        • Willerson J.T.
        • Goldblatt A.
        • et al.
        Serum digoxin concentrations in the human fetus, neonate and infant.
        N Engl J Med. 1972; 287: 1010
        • Sabol S.J.
        • Ward D.S.
        Effect of dopamine on hypoxic-hypercapnic interaction in humans.
        Anesth Analg. 1987; 66: 19
        • Sakamoto T.
        • Yamada T.
        Hemodynamic effects of dobutamine in patients following open heart surgery.
        Circulation. 1977; 55: 525
        • Samojlek E.
        • et al.
        Effects of dopamine on reproductive processes and fetal development in rats.
        Am J Obstet Gynecol. 1969; 104: 578
        • Schaer G.L.
        • Fink M.P.
        • Parillo J.E.
        Norepinephrine alone vs. norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy.
        Crit Care Med. 1985; 13: 492
        • Schatz M.
        • Zeiger R.S.
        • Harden K.M.
        • et al.
        The safety of inhaled β-agonist bronchodilators during pregnancy.
        J Allergy Clin Immunol. 1988; 82: 686
        • Schechter E.
        • Wilson M.F.
        • Yin-Suen K.o.ng.
        Physiologic responses to epinephrine infusion: The basis for a new stress for coronary artery disease.
        Am Heart J. 1983; 105: 554
        • Schlepper M.
        • Thormann J.
        • Kremer P.
        • et al.
        Present use of positive inotropic drugs in heart failure.
        J Cardiovasc Pharmacol. 1989; 14: S9
        • Schulze K.F.
        • Graff M.
        • Schimmel M.S.
        • et al.
        Physiologic oscillations produced by an infusion pump.
        J Pediatr. 1986; 103: 5
        • Seri I.
        • Tulassay T.
        • Kiszel J.
        Effect of low-dose dopamine infusion on prolactin and thyrotropin secretion in preterm infants with hyaline membrane disease.
        Biol Neonate. 1985; 47: 317
        • Seri I.
        • Tulassay T.
        • Kiszel J.
        • et al.
        Effect of low-dose dopamine therapy on catecholamine values in cerebrospinal fluid in preterm neonates.
        J Pediatr. 1980; 105: 489
        • Sherman J.L.
        • Locke R.V.
        Transplacental neonatal digitalis intoxication.
        Am J Cardiol. 1960; 6: 834
        • Smith R.E.
        • Briggs B.
        • Unverferth D.V.
        • et al.
        Dobutamine-induced inhibition of platelet function.
        Int J Clin Pharm Res. 1982; 2: 89
        • Smith T.
        • Butler V.
        • Haber E.
        • et al.
        Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments.
        N Engl J Med. 1982; 307: 1357
        • Smith T.W.
        • Haber E.
        • Yeatman L.
        • et al.
        Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies.
        N Engl J Med. 1976; 294: 797
        • Snow J.C.
        • Shamsai J.
        • Sakarya I.
        Effects of epinephrine during halothane anesthesia in mastoidotympanoplastic surgery.
        Anesth Analg. 1968; 47: 252
        • Solomon S.L.
        • Wallace E.M.
        • Ford-Jones E.L.
        • et al.
        Medication errors with inhalant epinephrine mimicking an epidemic of neonatal sepsis.
        N Engl J Med. 1984; 310: 166
        • Sperelakis N.
        Cyclic AMP and phosphorylation in regulation of Ca+2 influx into myocardial cells and blockade by calcium antagonist drugs.
        Am Heart J. 1984; 107: 347
        • Steen P.A.
        • Tinker J.H.
        • Pluth J.E.
        • et al.
        Efficacy of dopamine, dobutamine, and epinephrine during emergence from cardiopulmonary bypass in man.
        Circulation. 1978; 57: 378
        • Stolley P.D.
        Asthma mortality—why the United States was spared an epidemic of deaths due to asthma.
        Am Rev Respir Dis. 1972; 105: 883
        • Tinker J.H.
        • Tarkan S.
        • White R.D.
        Dobutamine for inotropic support during emergence from cardiopulmonary bypass.
        Anesthesiology. 1976; 44: 281
        • Treadway G.
        Clinical safety of intravenous amrinone—a review.
        Am J Cardiol. 1985; 56: 39
        • Turner E.S.
        • Greenberger P.A.
        • Patterson R.
        Management of the pregnant asthmatic patient.
        Ann Intern Med. 1980; 6: 905
        • Unverferth D.V.
        • Magorian R.D.
        • Lewis R.P.
        • et al.
        Long-term benefit of dobutamine in patients with congestive cardiomyopathy.
        Am Heart J. 1980; 100: 622
        • Urban j.
        • Radwan J.
        • Laudanski T.
        • et al.
        Dopamine influence on human uterine activity at term pregnancy.
        Br J Obstet Gynaecol. 1982; 89: 451
        • Ward A.
        • Brogden R.N.
        • Heel R.C.
        • et al.
        Amrinone—a preliminary review of its pharmacological properties and therapeutic use.
        Drags. 1983; 26: 468
        • Ward D.S.
        • Bellville J.W.
        Reduction of hypoxic ventilatory drive by dopamine.
        Anesth Anal. 1982; 61: 333
        • Weber K.T.
        • Andrews V.
        • Janicki J.S.
        • et al.
        Amrinone and exercise performance in patients with chronic heart failure.
        Am J Cardiol. 1981; 48: 164
        • Weiner N.
        Norepinephrine, epinephrine, and the sympathomimetic amines.
        in: Gilman A.G. Goodman L.S. Rail T.W. et a.l. The Pharmacologic Basis of Therapeutics. ed 7. Macmillan, New York1985 (chapter 8)
        • Weiner N.
        • Taylor P.
        Neurohumoral transmission: The autonomic and somatic motor nervous system.
        in: Gilman A.G. Goodman L.S. Rail T.W. et a.l. The Pharmacologic Basis of Therapeutics. ed 7. Macmillan, New York1985 (chapter 4)
        • Wilmshurst P.T.
        • et al.
        The effects of amrinone on platelet count, survival and function in patients with congestive heart failure.
        Br J Clin Pharmacol. 1984; 17: 317
        • Wilmshurst P.T.
        • Webb-Peploe M.M.
        Side effects of amrinone therapy.
        Br Heart J. 1983; 49: 447
        • Zaritsky A.L.
        • Chernow B.
        Catecholamines and other inotropes.
        in: Chernow B. The Pharmacologic Approach to the Critically Ill Patient. ed 2. Williams and Wilkins, Baltimore1988 (chapter 31)

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0749-0704(18)30297-5

      Copyright

      © 1991 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX